| Income Statement |
| Cost of Revenue | 3.88M |
|
| Gross Profit | -3.88M |
| Operating Expenses | 18.62M |
| Research and Development Expense | 8.55M |
| Selling, General and Administrative Expense | 15.20M |
| Operating Income | -22.50M |
| Net Income | -20.75M |
| Net Income Common Stock | -20.75M |
| Net Income Common Stock (USD) | -20.75M |
| Consolidated Income | -20.75M |
| Earnings per Basic Share | -0.23 |
| Earnings per Basic Share (USD) | -0.23 |
| Earnings per Diluted Share | -0.23 |
| Earning Before Interest & Taxes (EBIT) | -20.75M |
| Earning Before Interest & Taxes (USD) | -20.75M |
| Weighted Average Shares | 91.50M |
| Weighted Average Shares Diluted | 91.50M |
| Balance Sheet |
| Cash and Equivalents | 235.03M |
| Cash and Equivalents (USD) | 235.03M |
| Trade and Non-Trade Receivables | 300.00K |
| Current Assets | 225.56M |
| Property, Plant & Equipment Net | 53.03M |
| Total Assets | 293.10M |
| Current Liabilities | 5.75M |
| Total Liabilities | 42.24M |
| Accumulated Retained Earnings (Deficit) | -895.77M |
| Shareholders Equity | 250.86M |
| Shareholders Equity (USD) | 250.86M |
| Assets Non-Current | 67.54M |
| Deferred Revenue | 750.00K |
| Inventory | 1.60M |
| Liabilities Non-Current | 36.49M |
| Trade and Non-Trade Payables | 5.00M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 303.00K |
| Net Cash Flow from Financing | 35.76M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 23.36M |
| Capital Expenditure | -271.00K |
| Issuance (Purchase) of Equity Shares | 35.76M |
| Net Cash Flow from Investing | 354.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | 625.00K |
| Net Cash Flow from Operations | -12.75M |
| Share Based Compensation | 13.04M |